BECTON, DICKINSON AND COMPANY Company Becton, Dickinson and Company BOERSE MUENCHEN
Equities
BOX
US0758871091
Medical Equipment, Supplies & Distribution
|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 217.9 EUR | +0.18% |
|
-2.33% | -1.36% |
Business Summary
- medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.;
- diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.;
- clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc.
Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sales per Business
| USD in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Medical
49.1
%
| 8,841 | 46.9 % | 9,502 | 49.1 % | +7.48% |
Life Sciences
26.5
%
| 5,564 | 29.5 % | 5,133 | 26.5 % | -7.75% |
Interventional
24.4
%
| 4,464 | 23.7 % | 4,736 | 24.4 % | +6.09% |
Sales per region
| USD in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
United States
57.4
%
| 10,722 | 56.8 % | 11,113 | 57.4 % | +3.65% |
EMEA
21.9
%
| 4,043 | 21.4 % | 4,244 | 21.9 % | +4.97% |
Greater Asia
15.0
%
| 3,047 | 16.1 % | 2,913 | 15.0 % | -4.40% |
Other
5.7
%
| 1,058 | 5.6 % | 1,102 | 5.7 % | +4.16% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
Thomas Polen
CEO | Chief Executive Officer | 50 | 01/09/01 |
| Director of Finance/CFO | 52 | 06/21/06 | |
| Chief Tech/Sci/R&D Officer | 48 | 01/19/01 | |
Joseph Smith
CTO | Chief Tech/Sci/R&D Officer | - | 29/21/29 |
Denise Fleming
CTO | Chief Tech/Sci/R&D Officer | 54 | 01/22/01 |
Ronald Silverman
CTO | Chief Tech/Sci/R&D Officer | 54 | 04/12 |
Claudia Curtis
CMP | Compliance Officer | - | 01/04/01 |
Ami Simunovich
IRO | Public Communications Contact | - | 01/18/01 |
Gregory Rodetis
IRC | Investor Relations Contact | - | 01/16/01 |
Michelle Quinn
LAW | General Counsel | 56 | 01/19/01 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
Bertram Scott
BRD | Director/Board Member | 73 | 24/02/24 |
Catherine Burzik
BRD | Director/Board Member | 73 | 29/13/29 |
| Director/Board Member | 69 | 26/10/26 | |
| Director/Board Member | 59 | 10/18/10 | |
Timothy Ring
BRD | Director/Board Member | 66 | 29/17/29 |
Andy Eckert
BRD | Director/Board Member | 62 | 23/16/23 |
| Director/Board Member | 68 | 20/06/20 | |
Bill Brown
BRD | Director/Board Member | 61 | 28/22/28 |
Thomas Polen
CEO | Chief Executive Officer | 50 | 01/09/01 |
Carrie Byington
BRD | Director/Board Member | 61 | 21/21/21 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 370,594,401 | 288,100,561 ( 77.74 %) | 80,202,608 ( 21.64 %) | 77.74 % |
Company contact information
Group companies
| Name | Category and Sector |
|---|---|
Becton Dickinson India Pvt Ltd.
| |
Becton Dickinson Luxembourg Finance SARL
| |
Becton, Dickinson & Co. Master Retirement Trust
| |
Employees Retirement Plan of C.R. Bard, Inc.
 Employees Retirement Plan of C.R. Bard, Inc. Investment ManagersFinance The Employees Retirement Plan of C.R. Bard, Inc. provides retirement benefit services. The private company is located in the US. |
Investment Managers
|
Becton Dickinson Euro Finance SARL
 Becton Dickinson Euro Finance SARL Finance/Rental/LeasingFinance Part of Becton, Dickinson & Co., Becton Dickinson Euro Finance SARL is a financing subsidiary/special purpose entity. The company is based in Luxembourg, Luxembourg. |
Finance/Rental/Leasing
|
Becton, Dickinson BV
 Becton, Dickinson BV Medical SpecialtiesHealth Technology Part of Becton, Dickinson & Co., Becton, Dickinson BV is a Dutch company that manufactures and wholesales medical, surgical & pharmaceutical products. The company is based in Vianen, Netherlands. The CEO of the company is Vincent A. Forlenza. |
Medical Specialties
|
Sector
Sales per Business
Sales per region
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
233.7
USD
Average target price
279.2
USD
Spread / Average Target
+19.46%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -5.60% | 181B | |
| -4.45% | 101B | |
| -8.63% | 45.09B | |
| +9.70% | 44.37B | |
| +5.36% | 40.7B | |
| +15.22% | 29.85B | |
| +10.26% | 24.49B | |
| -6.46% | 23.99B | |
| -10.82% | 22.33B |
- Stock Market
- Equities
- BDX Stock
- BOX Stock
- Company Becton, Dickinson and Company
